GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PeptiDream Inc (OTCPK:PPTDF) » Definitions » EV-to-EBIT

PPTDF (PeptiDream) EV-to-EBIT : 11.05 (As of May. 21, 2025)


View and export this data going back to 2014. Start your Free Trial

What is PeptiDream EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, PeptiDream's Enterprise Value is $1,483.5 Mil. PeptiDream's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was $134.2 Mil. Therefore, PeptiDream's EV-to-EBIT for today is 11.05.

The historical rank and industry rank for PeptiDream's EV-to-EBIT or its related term are showing as below:

PPTDF' s EV-to-EBIT Range Over the Past 10 Years
Min: -59527.07   Med: 122.84   Max: 2072.38
Current: 10.12

During the past 13 years, the highest EV-to-EBIT of PeptiDream was 2072.38. The lowest was -59527.07. And the median was 122.84.

PPTDF's EV-to-EBIT is ranked worse than
52.42% of 475 companies
in the Biotechnology industry
Industry Median: 8.09 vs PPTDF: 10.12

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. PeptiDream's Enterprise Value for the quarter that ended in Mar. 2025 was $2,202.9 Mil. PeptiDream's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was $134.2 Mil. PeptiDream's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 6.09%.


PeptiDream EV-to-EBIT Historical Data

The historical data trend for PeptiDream's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PeptiDream EV-to-EBIT Chart

PeptiDream Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 93.20 83.76 31.84 29.57 14.58

PeptiDream Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.48 9.80 12.82 14.58 12.44

Competitive Comparison of PeptiDream's EV-to-EBIT

For the Biotechnology subindustry, PeptiDream's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PeptiDream's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PeptiDream's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PeptiDream's EV-to-EBIT falls into.


;
;

PeptiDream EV-to-EBIT Calculation

PeptiDream's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1483.472/134.201
=11.05

PeptiDream's current Enterprise Value is $1,483.5 Mil.
PeptiDream's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $134.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PeptiDream  (OTCPK:PPTDF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

PeptiDream's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 ) =EBIT / Enterprise Value (Q: Mar. 2025 )
=134.201/2202.9022
=6.09 %

PeptiDream's Enterprise Value for the quarter that ended in Mar. 2025 was $2,202.9 Mil.
PeptiDream's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $134.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PeptiDream EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of PeptiDream's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


PeptiDream Business Description

Traded in Other Exchanges
Address
1-2-10, Nihonbashi, Chuo-ku, Toyo Building, 6th Floor, Tokyo, JPN, 103-0027
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.